The court last month ordered an “interim status quo” on the deal, pending a decision on a petition for a probe into alleged insider trading.
High Court Lifts Stay on Sun Pharma’s $3.2 Billion Ranbaxy Takeover
Published in News
More from NewsMore posts in News »
- Three Reasons Why Sensex Reclaimed Mt 50K and Nifty Crossed 15K – Investing.com India
- Tata Motors loss down to ₹7,605 cr in Q4; revenue growth up 42% – BusinessLine
- Tata Motors to double capex of India business up to Rs 3,500 crore on robust turnaround of PV unit – Moneycontrol.com
- “Never Exported Vaccines At Cost Of People In India”: Adar Poonawalla – NDTV
- Markets extend gains as sensex soars 613 points; Nifty settles above 15,100 – Times of India
